title: Geography: an increasingly important variable in prostate cancer clinical trials.
authors.affiliation: Tulane Medical School, New Orleans, LA, USA. osartor@tulane.edu.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.forename: Sumanta Kumar
authors.initials: SK
authors.lastname: Pal
authors.forename: Terhi
authors.initials: T
authors.lastname: Hermanson
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide